Human Genome Sciences, Inc. (Nasdaq: HGSI) announced today that the U.S. FDA has acknowledged receipt of the resubmission of the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE